Clinical trialObsRecruiting
Use Of Indocyanine Green In Pancreas Surgery
Assessing the Role of Intraoperative Indocyanine Green Perfusion of the Transected Pancreas in Predicting Postoperative Pancreatic Leaks
- Outcome
- Ongoing
- Phase
- Obs
- Status
- Recruiting
- Study type
- Observational
- Start
- 29 February 2024
- Expected end
- 28 February 2028
- Enrollment
- 55 participants
- Sites
- 1
- Primary outcomes
- Incidence of biochemical leak or fistula after pancreatectomy.; Perfusion status
- Sponsor
- Other
- Results posted
- No
- Last update
- 31 August 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This study evaluates the use of indocyanine green to predict postoperative pancreatic leaks in patients undergoing transection of the pancreas.
Detailed description public domain (ClinicalTrials.gov)
PRIMARY OBJECTIVE: I. To determine if altered measurement results of ICG after pancreatectomy is associated with leak rates. OUTLINE: This is an observational study. Patients receive indocyanine green intravenously (IV) during surgery, undergo imaging and have their medical records reviewed on study.